Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Posting of Annual Report and Notice of AGM

25th Jul 2018 17:21

RNS Number : 7870V
Collagen Solutions PLC
25 July 2018
 

 

25 July 2018

Collagen Solutions plc

("Collagen Solutions" or the "Company")

 

Posting of Annual Report and Notice of AGM

 

Collagen Solutions plc (AIM: COS), the developer and manufacturer of biomaterials and regenerative medicines for the enhancement and extension of human life, confirms that the Annual Report and Accounts for the year ended 31 March 2018 ('2018 Annual Report and Accounts'), the Notice of Annual General Meeting ('AGM') and a Form of Proxy will be posted to shareholders on 26 July 2018. A copy of the 2018 Annual Report and Accounts will be available to download from the Company website from that date.

 

The AGM will be held at 11.00am on 22 August 2018 at 3 Robroyston Oval, Nova Business Park, Glasgow G33 1AP.

 

For additional information on Collagen Solutions, please visit: www.collagensolutions.com

 

 

Collagen Solutions Plc

 

Jamal Rushdy, CEO 

Via Walbrook

Hilary Spence, CFO

 

Lisa Baderoon, Investor Relations

 

Mob: 07721 413 496 or [email protected]

 

 

Cenkos Securities Plc (Nominated Adviser and Broker)

 

Steve Cox (Corporate Finance)

Tel: 0207 397 8900

Stephen Keys

 

 

 

Walbrook PR Ltd

Tel: 020 7933 8780 or [email protected]

Anna Dunphy

Mob: 07876 741 001

Helen Cresswell

Mob: 07841 917 679

 

 

About Collagen Solutions:

Collagen Solutions Plc is a global supplier, developer, and manufacturer of medical grade collagen, tissues, and related medical devices and components for use in regenerative medicine, medical devices and in-vitro diagnostics and research. The Company is also expanding its range of biomaterials-based finished medical devices based on its internal and acquired intellectual property for commercialisation with partners via licensing and distribution arrangements, including ChondroMimetic®. The Company's products are used in a wide variety of applications including orthopaedics, cardiovascular, dental, plastic surgery, wound healing, neurology and urology.

 

For more information go to: www.collagensolutions.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
MSCPGUMGMUPRGQA

Related Shares:

COS.L
FTSE 100 Latest
Value8,275.66
Change0.00